Semaglutide FAQ: common questions answered
A GLP-1 medicine with strong weight, glucose, heart and kidney evidence; dose and formulation matter.
Also called: Ozempic, Wegovy, Wegovy HD, Wegovy FlexTouch, Rybelsus, oral semaglutide, NN9535, NN9924.
GLP-1 / GIP / glucagon agonists · GLP-1 receptor agonist · Evidence: Approved drug.
- Is Semaglutide FDA-approved? Yes: Ozempic injection (adults: type 2 diabetes; heart-event reduction with established disease; kidney-risk reduction with diabetic CKD.); Rybelsus (adults: type 2 diabetes; major cardiovascular event reduction in those at high risk.); Ozempic tablets (adult type 2 diabetes and major cardiovascular event reduction in those at high risk; oral 1.5/4/9 mg formulation.). 503A discretion ended after the April 24, 2025 ruling; 503B ended May 22. April 2026 proposed 503B exclusion is not final. Semaglutide salts lack a lawful basis.
- How do people take it? Under the skin, once weekly. Source: drug label.
- What's the difference between Semaglutide and Cagrilintide? Semaglutide: a GLP-1 medicine with strong weight, glucose, heart and kidney evidence; dose and formulation matter. Cagrilintide: an unapproved weekly amylin analogue with weight-loss trials and common stomach symptoms. Why people pair them: trials combine amylin and GLP-1 activity for greater weight reduction.
- Can I take it with Cagrilintide? Trials combine amylin and GLP-1 activity for greater weight reduction. Controlled CagriSema trials do not validate home-mixed or independently sourced ingredients. Source: studied in a trial. Ask a doctor before combining anything.
- Is it banned in sport? Not banned. It is on the watch list (WADA 2026). Semaglutide markers monitored in and out of competition. Monitoring does not mean prohibited.
- How do I store it once opened? No mixing for approved products. Used Ozempic or Wegovy FlexTouch pens: 56 days refrigerated or at 15–30°C.
Related to Semaglutide
- Tirzepatide: A weekly GIP/GLP-1 injection with strong diabetes and weight-loss evidence and common stomach side effects.
- Retatrutide: An experimental weekly injection with phase 3 weight-loss results.
- Liraglutide: A daily GLP-1 injection approved for weight management and type 2 diabetes.
- Dulaglutide: A weekly GLP-1 medicine approved for type 2 diabetes and lower heart-event risk.
- Exenatide: An older GLP-1 with twice-daily and weekly forms, now widely discontinued.
- Cagrilintide: An unapproved weekly amylin analogue with weight-loss trials and common stomach symptoms.
Sources
- Canada approves first generic semaglutide for weight loss, 2026
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, FDA · 2026
- FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List, FDA · 2026
- FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications, FDA · 2026
- FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s, 2026
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, FDA · FDA · 2026
- First GLP-1 tablet for weight loss approved in the UK, 2026
- Ozempic injection US prescribing information, July 2026; DailyMed Set ID 42bdd912-2393-44c4-b7e0-47672ca28991, 2026
- Rybelsus, INN-semaglutide, 2026
- Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity, 2026
- The 2026 Monitoring Program, World Anti-Doping Agency · 2026
- These highlights do not include all the information needed to use RYBELSUS ® and OZEMPIC® tablets safely and effectively. See full prescribing information for RYBELSUS and OZEMPIC tablets. RYBELSUS (semaglutide) tablets, for oral use OZEMPIC (semaglutide) tablets, for oral use Initial U.S. Approval: 2017, 2026
- Wegovy semaglutide prescribing information: injection strengths, DailyMed · 2026
- WEGOVY- semaglutide injection, solution WEGOVY- semaglutide tablet, DailyMed · DailyMed · 2026
- Wegovy, INN-semaglutide, 2026
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.